Adempas?

What is Adempas (riociguat) used for?

Adempas is a prescription medicine called riociguat. It’s used to treat adults with certain types of pulmonary hypertension, specifically:
- Pulmonary arterial hypertension (PAH, WHO Group 1) to improve exercise capacity and delay clinical worsening.
- Chronic thromboembolic pulmonary hypertension (CTEPH, WHO Group 4) when disease is not operable by surgery or after surgery if pulmonary hypertension persists.

How does Adempas work?

Adempas contains riociguat, which helps relax blood vessels in the lungs. It improves the pathway that increases blood flow by targeting nitric-oxide signaling and related mechanisms, which can reduce pulmonary vascular resistance.

Who can’t take Adempas?

Adempas may be unsafe or contraindicated in people who:
- Are taking medicines that affect the same nitric-oxide pathway (including certain nitrates and some drugs for erectile dysfunction). Drug interactions can cause dangerous drops in blood pressure.
- Are pregnant, because it can harm a developing fetus.
- Have specific low blood pressure or other conditions where vasodilation would be risky (clinician assessment is required).

What side effects are patients asking about?

Commonly reported side effects include:
- Headache
- Dizziness
- Gastrointestinal symptoms such as nausea or dyspepsia
- Low blood pressure–related symptoms (for example, feeling faint)
Patients are usually counseled to report signs of low blood pressure or other concerning symptoms promptly.

How is Adempas taken and adjusted?

Adempas is taken by mouth, with dosing adjusted by a clinician based on tolerability and blood pressure response. Regular follow-up matters because dose changes are part of how safety is managed.

Drug interactions: what should be avoided with Adempas?

People using Adempas generally need to avoid:
- Nitrates (used for angina) and other nitrate-like therapies
- PDE5 inhibitors (commonly used for erectile dysfunction) because the combination can cause significant blood pressure lowering
Always tell the prescribing clinician about all prescriptions, over-the-counter medicines, and supplements.

Is Adempas pregnancy-safe?

No. Adempas is considered harmful during pregnancy. Women who can become pregnant must use effective contraception and follow the prescriber’s pregnancy testing schedule while on treatment.

Is Adempas approved everywhere and who makes it?

Adempas is a branded prescription drug. The exact commercial availability and manufacturer details can vary by country, and can be confirmed through local prescribing information or the pharmacy system.

If you’re comparing Adempas to other pulmonary hypertension drugs, what’s the difference?

Adempas is in a class that targets the nitric-oxide pathway (a soluble guanylate cyclase stimulator). Other pulmonary hypertension options work through different mechanisms (for example endothelin receptor antagonists or prostacyclin pathway therapies). The choice depends on the specific pulmonary hypertension subtype and patient factors.

What happens if treatment is interrupted?

Stopping Adempas can worsen pulmonary hypertension control in some patients. Dose changes or discontinuation should be done only with a clinician’s guidance.

What should you ask your doctor about Adempas?

Typical high-yield questions include:
- Which diagnosis you have (PAH vs CTEPH) and why that determines choice
- How your blood pressure and labs will be monitored
- Your medication list for interaction risk
- Contraception and pregnancy-testing requirements (if applicable)
- What to do if you miss a dose

If you tell me what you’re trying to figure out about Adempas (uses, side effects, dosing, interactions, pregnancy safety, cost/availability, or comparisons), I can tailor the answer to that specific concern.